Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
|
Radiother Oncol
|
2006
|
6.44
|
2
|
Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging.
|
J Clin Oncol
|
2013
|
2.91
|
3
|
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
|
J Clin Oncol
|
2008
|
2.23
|
4
|
Gynaecological cancers in pregnancy.
|
Lancet
|
2012
|
2.11
|
5
|
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
|
Ann Surg Oncol
|
2004
|
1.75
|
6
|
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.75
|
7
|
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.
|
Radiother Oncol
|
2012
|
1.54
|
8
|
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).
|
Ann Surg Oncol
|
2010
|
1.53
|
9
|
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients.
|
Gynecol Oncol
|
2004
|
1.37
|
10
|
Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations.
|
Radiother Oncol
|
2008
|
1.18
|
11
|
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
|
Radiother Oncol
|
2012
|
1.17
|
12
|
Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.17
|
13
|
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.16
|
14
|
Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
|
Cancer
|
2008
|
1.10
|
15
|
Nodal-staging surgery for locally advanced cervical cancer in the era of PET.
|
Lancet Oncol
|
2012
|
1.08
|
16
|
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
|
Ann Surg Oncol
|
2007
|
1.08
|
17
|
Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.07
|
18
|
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.
|
Oncologist
|
2010
|
1.05
|
19
|
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.04
|
20
|
[Role of radiotherapy in recurrent gliomas].
|
Bull Cancer
|
2004
|
1.00
|
21
|
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique.
|
Int J Gynecol Cancer
|
2011
|
1.00
|
22
|
New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
|
Cancer Treat Rev
|
2008
|
0.99
|
23
|
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
|
Oncologist
|
2012
|
0.98
|
24
|
Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.
|
Oncologist
|
2011
|
0.96
|
25
|
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
|
Radiother Oncol
|
2006
|
0.95
|
26
|
Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.94
|
27
|
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies.
|
J Am Coll Surg
|
2002
|
0.94
|
28
|
Overview of brachytherapy resources in Latin America: a patterns-of-care survey.
|
Brachytherapy
|
2011
|
0.92
|
29
|
Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies.
|
Brachytherapy
|
2010
|
0.91
|
30
|
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
|
Eur J Cancer
|
2010
|
0.90
|
31
|
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
|
Oncologist
|
2011
|
0.90
|
32
|
Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer.
|
Oncologist
|
2013
|
0.89
|
33
|
Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
|
Ann Surg Oncol
|
2005
|
0.89
|
34
|
American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.
|
Brachytherapy
|
2013
|
0.89
|
35
|
Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.89
|
36
|
Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy.
|
Radiother Oncol
|
2008
|
0.88
|
37
|
Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression.
|
Eur J Obstet Gynecol Reprod Biol
|
2006
|
0.87
|
38
|
Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.
|
Radiother Oncol
|
2002
|
0.86
|
39
|
Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.85
|
40
|
Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
|
J Pediatr Surg
|
2009
|
0.84
|
41
|
[Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
|
Bull Cancer
|
2005
|
0.82
|
42
|
[Effects of radiotherapy (external and/or internal) and chemotherapy on female fertility].
|
Bull Acad Natl Med
|
2010
|
0.82
|
43
|
Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging.
|
Clin Imaging
|
2012
|
0.82
|
44
|
Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
|
Radiother Oncol
|
2012
|
0.80
|
45
|
The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.
|
Eur J Cancer
|
2008
|
0.80
|
46
|
[Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)].
|
Bull Cancer
|
2003
|
0.80
|
47
|
Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.80
|
48
|
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
|
Hum Reprod
|
2011
|
0.80
|
49
|
[Conservative management of malignant and borderline ovarian tumor].
|
Bull Cancer
|
2002
|
0.78
|
50
|
[Gynecological cancers and pregnancy: the point of view of the oncology gynecologist].
|
Bull Cancer
|
2002
|
0.78
|
51
|
Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.78
|
52
|
Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives.
|
Lancet Oncol
|
2007
|
0.78
|
53
|
Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
|
Radiother Oncol
|
2004
|
0.77
|
54
|
Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer.
|
Anticancer Res
|
2010
|
0.77
|
55
|
[Medical treatment of metastatic or recurrent cancer of the cervix].
|
Bull Cancer
|
2006
|
0.77
|
56
|
Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d'Orsay.
|
Strahlenther Onkol
|
2002
|
0.77
|
57
|
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
|
Int J Gynecol Cancer
|
2015
|
0.76
|
58
|
Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.
|
Int J Gynaecol Obstet
|
2013
|
0.76
|
59
|
Cancer during pregnancy: the time has come for a prospective program.
|
J Clin Oncol
|
2009
|
0.76
|
60
|
[Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].
|
Bull Cancer
|
2013
|
0.76
|
61
|
Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
|
Int J Gynecol Cancer
|
2010
|
0.76
|
62
|
Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy: should "staging" conization be systematically performed before this procedure?
|
Int J Gynecol Cancer
|
2013
|
0.76
|
63
|
Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia.
|
Oncologist
|
2011
|
0.75
|
64
|
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents.
|
Cancer Metastasis Rev
|
2008
|
0.75
|
65
|
Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.
|
J Am Coll Surg
|
2010
|
0.75
|
66
|
[Radiation therapy for chordomas and chondrosarcomas of the base of the skull and cervical spine].
|
Bull Cancer
|
2002
|
0.75
|
67
|
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved].
|
Bull Cancer
|
2012
|
0.75
|
68
|
[What hysterectomy procedure should be carried out for cancer of the endometrium in stage I-II].
|
Bull Cancer
|
2002
|
0.75
|
69
|
Therapy Insight: fertility in women after cancer treatment.
|
Nat Clin Pract Endocrinol Metab
|
2007
|
0.75
|
70
|
Laparoscopic radical hysterectomy after preoperative brachytherapy for stage IB1 cervical cancer: feasibility, results, and surgical implications in a large bicentric study of 162 consecutive cases.
|
Ann Surg Oncol
|
2012
|
0.75
|
71
|
[French recommendations for endometrial cancer 2010: clinical use and questions still debated].
|
Bull Cancer
|
2012
|
0.75
|
72
|
Clear cell adenocarcinoma of the female genital tract: long-term outcome and fertility aspects after brachytherapy aimed at a conservative treatment.
|
Int J Gynecol Cancer
|
2012
|
0.75
|
73
|
Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO.
|
Radiother Oncol
|
2004
|
0.75
|
74
|
Sentinel lymph node in endometrial cancer: a review.
|
Curr Oncol Rep
|
2013
|
0.75
|
75
|
Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives.
|
Curr Opin Oncol
|
2016
|
0.75
|
76
|
Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
|
Pediatr Blood Cancer
|
2013
|
0.75
|
77
|
[Sentinel lymph nodes in gynecologic cancers].
|
Bull Cancer
|
2002
|
0.75
|